Join our daily newsletter At The Bell to receive exclusive market insights
- Nanoveu (NVU) shares have soared after securing Nestlé Professional as a customer for its Nanoshield screen protectors for coffee machines
- The Nanoshield protectors will be customised to precisely fit the Nescafé touch screen and touch pad coffee machines
- Nestle have ordered US$50,000 (roughly A$65,000) worth of the product, with the possibility of more orders to come
- Nestlé Professional undertook an evaluation of Nanoshield at the Nestlé Institute of Food Safety and Analytical Sciences in Switzerland prior to selecting NVU as its supplier
- Nanoveu shares are up 108 per cent, trading at 11 cents
Nanoveu (NVU) has secured Nestlé Professional as a customer for its Nanoshield screen protectors for coffee machines.
The Nanoshield protectors will be customised to precisely fit the Nescafé touch screen and touch pad coffee machines, which are available around the world.
Nestlé have ordered US$50,000 (roughly A$65,000) worth of the product, with the possibility of more orders to come. However, the agreement does not come with a fixed-term contract.
Nestlé says as a result of the COVID-19 pandemic, consumers are looking for more reassurance for safety and hygiene when they have a coffee on-the-go, at work or a convenience store. The implementation of the Nanoshield technology is an effort to provide solutions adapted to the current sanitary situation.
Before choosing Nanoveu as its supplier, Nestlé Professional undertook its own evaluation of Nanoshield at the Nestlé Institute of Food Safety and Analytical Sciences in Switzerland to scientifically validate a variety of anti-viral solutions.
Nanoveu was later advised the study results, which will be published in a peer reviewed journal.
“The screen protections are a great solution because they can be easily used on current beverage machines and complement existing enhanced hygiene measures we already have in place for our coffee solutions,” said Head of Research and Development for Nestlé Professional, Zenon Mandralis.
Nanoveu’s antiviral technology has been independently demonstrated to be a highly effective agent for the eradication of viruses. The technology has been proven to eliminate almost 100 per cent of the viral strain affecting humans that is also a surrogate for COVID-19, within a 30-minute time frame.
Nanoveu has skyrocketed up 108 per cent, trading at 11 cents at 11:40 am AEDT.
